Role and Interactions of Annexin A1 and Oestrogens in the Manifestation of Sexual Dimorphisms in Cerebral and Systemic Inflammation
Overview
Affiliations
Background And Purpose: Gender differences in inflammation are well described, with females often showing more robust, oestrogen-associated responses. Here, we investigated the influence of gender, oestrogen and the anti-inflammatory protein annexin A1 (AnxA1) on lipopolysaccharide (LPS)-induced leukocyte-endothelial cell interactions in murine cerebral and mesenteric microvascular beds.
Experimental Approach: Intravital microscopy was used to visualize and quantify the effects of LPS (10 μg·per mouse i.p.) on leukocyte-endothelial interactions in male and female wild-type (WT) mice. The effects of ovariectomy ± oestrogen replacement were examined in WT and AnxA1-null (AnxA1(-/-) ) female mice.
Key Results: LPS increased leukocyte adherence in the cerebral and mesenteric beds of both male and female WT mice; females showed exacerbated responses in the brain versus males, but not the mesentery. Ovariectomy further enhanced LPS-induced adhesion in the brain but not the mesentery; its effects were reversed by oestrogen treatment. OVX AnxA1(-/-) mice also showed exaggerated adhesive responses to LPS in the brain. However, these were unresponsive to ovariectomy and, paradoxically, responded to oestrogen with a pronounced increase in basal and LPS-induced leukocyte adhesion in the cerebrovasculature.
Conclusions And Implications: Our data confirm the fundamental role of AnxA1 in limiting the inflammatory response in the central and peripheral microvasculature. They also (i) show that oestrogen acts via an AnxA1-dependent mechanism to protect the cerebral, but not the mesenteric, vasculature from the damaging effects of LPS and (ii) reveal a paradoxical and potentially toxic effect of the steroid in potentiating the central response to LPS in the absence of AnxA1.
Scott C, Neira Agonh D, White H, Sultana S, Lehmann C Int J Mol Sci. 2023; 24(22).
PMID: 38003533 PMC: 10671110. DOI: 10.3390/ijms242216345.
Eduarda de Albuquerque Borborema M, de Lucena T, de Azevedo Silva J Genet Mol Biol. 2023; 46(1 Suppl 2):e20220158.
PMID: 36745756 PMC: 9901533. DOI: 10.1590/1415-4757-GMB-2022-0158.
Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M, Kozirog E, Wilczynski J Int J Environ Res Public Health. 2022; 19(4).
PMID: 35206475 PMC: 8872164. DOI: 10.3390/ijerph19042294.
Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism.
Xiao W, Oldham W, Priolo C, Pandey A, Loscalzo J Circ Res. 2021; 129(1):9-29.
PMID: 33890812 PMC: 8221540. DOI: 10.1161/CIRCRESAHA.120.318805.
Loiola R, Wickstead E, Solito E, McArthur S Front Endocrinol (Lausanne). 2019; 10:420.
PMID: 31297095 PMC: 6607409. DOI: 10.3389/fendo.2019.00420.